High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran

Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC microbiology 2023-04, Vol.23 (1)
Hauptverfasser: Afsharikhah, Saleh, Ghanbarpour, Reza, Mohseni, Parvin, Adib, Nasrin, Bagheri, Mahboube, Jajarmi, Maziar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page
container_title BMC microbiology
container_volume 23
creator Afsharikhah, Saleh
Ghanbarpour, Reza
Mohseni, Parvin
Adib, Nasrin
Bagheri, Mahboube
Jajarmi, Maziar
description Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common [beta]-lactam resistance genes including bla.sub.TEM, bla.sub.SHV, bla.sub.CTX-M and bla.sub.CMY and phenotypic resistance to commonly used [beta]-lactam and fluoroquinolone antibiotics in UTIs. These factors were evaluated in various phylogenetic groups (phylotypes) of E. coli isolates. Real-time PCR was applied to detect [beta]-lactam resistance genes and conventional PCR was used to determine the phylotypes. Phenotypic resistance against [beta]-lactams (ceftazidime, cefotaxime, aztreonam and ceftriaxone) and fluoroquinolones (ciprofloxacin) were identified by the disc diffusion technique. The ability of extended spectrum [beta]-lactamases (ESBLs) production in E. coli isolates was detected using the combined disc diffusion method. The prevalence of resistance genes were 89.6% for bla.sub.TEM, 44.3% for bla.sub.CTX-M, 6.6% for bla.sub.SHV and 0.9% for bla.sub.CMY. The two high prevalent phylotypes were B2 (29.2%) and D (17.9%) followed by E (14.1%), F (9.4%), C (6.6%) and 10.3% of isolates were unknown in phylotyping. Disc diffusion results showed high prevalence of antibiotic resistance to cefotaxime (88.6%), aztreonam (83%), ceftireaxon (77.3%), ceftazidime (76.4%) and ciprofloxacin (55.6%). Totally, 52.8% of isolates were found as phenotypical ESBL-producers. This study's results confirmed an explosion of antibiotic resistance amongst E. coli isolates from UTI against [beta]-lactams and fluoroquinolones. Findings explain the necessity of deep changes in quantity and quality of drug resistance diagnosis and antibiotic therapy strategies. More studies are suggested to better and confident evaluations.
doi_str_mv 10.1186/s12866-023-02860-7
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A746669836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A746669836</galeid><sourcerecordid>A746669836</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1016-eb9018434ff70d639f48d8a247284e2213f041f9af87b65d09021c880e971c7b3</originalsourceid><addsrcrecordid>eNptkN9LwzAQx4soOKf_gE8BnwQ7kzQm6eMY6iYDwR9PIiNNkzbSNTNJh_2D_D9N0YcN5DjuuPvc945LknMEJwhxeu0R5pSmEGfROYUpO0hGiDCUYsTh4U5-nJx4_wEhYjxjo-R7bqoabJzaika1UgGrwVuhgnhPGyGDWAPRlkA3nXX2szOtbWyrgFPe-CAG3rRgK5yxnQebum9s6DfKDyq3XtbKGVkbAaRtDDDeNiLEpnZ2DTpnWuF6EFxcE1W0ksHY1g-CD8ZZHYA0ob8CCyfa0-RIi8ars784Tl7vbl9m83T5eL-YTZdphSCiqSpyiDjJiNYMljTLNeElF5gwzInCGGUaEqRzoTkr6E0Jc4iR5ByqnCHJimycXPzqVvEbq3iUHc5bGy9XU0YopTnPaKQm_1DRSrU2Mv5Hm1jfG7jcG4hMUF-hEp33q8Xz0y77AxM7jl8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran</title><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Afsharikhah, Saleh ; Ghanbarpour, Reza ; Mohseni, Parvin ; Adib, Nasrin ; Bagheri, Mahboube ; Jajarmi, Maziar</creator><creatorcontrib>Afsharikhah, Saleh ; Ghanbarpour, Reza ; Mohseni, Parvin ; Adib, Nasrin ; Bagheri, Mahboube ; Jajarmi, Maziar</creatorcontrib><description>Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common [beta]-lactam resistance genes including bla.sub.TEM, bla.sub.SHV, bla.sub.CTX-M and bla.sub.CMY and phenotypic resistance to commonly used [beta]-lactam and fluoroquinolone antibiotics in UTIs. These factors were evaluated in various phylogenetic groups (phylotypes) of E. coli isolates. Real-time PCR was applied to detect [beta]-lactam resistance genes and conventional PCR was used to determine the phylotypes. Phenotypic resistance against [beta]-lactams (ceftazidime, cefotaxime, aztreonam and ceftriaxone) and fluoroquinolones (ciprofloxacin) were identified by the disc diffusion technique. The ability of extended spectrum [beta]-lactamases (ESBLs) production in E. coli isolates was detected using the combined disc diffusion method. The prevalence of resistance genes were 89.6% for bla.sub.TEM, 44.3% for bla.sub.CTX-M, 6.6% for bla.sub.SHV and 0.9% for bla.sub.CMY. The two high prevalent phylotypes were B2 (29.2%) and D (17.9%) followed by E (14.1%), F (9.4%), C (6.6%) and 10.3% of isolates were unknown in phylotyping. Disc diffusion results showed high prevalence of antibiotic resistance to cefotaxime (88.6%), aztreonam (83%), ceftireaxon (77.3%), ceftazidime (76.4%) and ciprofloxacin (55.6%). Totally, 52.8% of isolates were found as phenotypical ESBL-producers. This study's results confirmed an explosion of antibiotic resistance amongst E. coli isolates from UTI against [beta]-lactams and fluoroquinolones. Findings explain the necessity of deep changes in quantity and quality of drug resistance diagnosis and antibiotic therapy strategies. More studies are suggested to better and confident evaluations.</description><identifier>ISSN: 1471-2180</identifier><identifier>EISSN: 1471-2180</identifier><identifier>DOI: 10.1186/s12866-023-02860-7</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Beta lactamases ; Causes of ; Ciprofloxacin ; Communicable diseases ; Drug resistance in microorganisms ; Drug therapy ; Escherichia coli ; Genetic aspects ; Identification and classification ; Phylogeny ; Risk factors ; Statistics ; Urinary tract infections</subject><ispartof>BMC microbiology, 2023-04, Vol.23 (1)</ispartof><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Afsharikhah, Saleh</creatorcontrib><creatorcontrib>Ghanbarpour, Reza</creatorcontrib><creatorcontrib>Mohseni, Parvin</creatorcontrib><creatorcontrib>Adib, Nasrin</creatorcontrib><creatorcontrib>Bagheri, Mahboube</creatorcontrib><creatorcontrib>Jajarmi, Maziar</creatorcontrib><title>High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran</title><title>BMC microbiology</title><description>Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common [beta]-lactam resistance genes including bla.sub.TEM, bla.sub.SHV, bla.sub.CTX-M and bla.sub.CMY and phenotypic resistance to commonly used [beta]-lactam and fluoroquinolone antibiotics in UTIs. These factors were evaluated in various phylogenetic groups (phylotypes) of E. coli isolates. Real-time PCR was applied to detect [beta]-lactam resistance genes and conventional PCR was used to determine the phylotypes. Phenotypic resistance against [beta]-lactams (ceftazidime, cefotaxime, aztreonam and ceftriaxone) and fluoroquinolones (ciprofloxacin) were identified by the disc diffusion technique. The ability of extended spectrum [beta]-lactamases (ESBLs) production in E. coli isolates was detected using the combined disc diffusion method. The prevalence of resistance genes were 89.6% for bla.sub.TEM, 44.3% for bla.sub.CTX-M, 6.6% for bla.sub.SHV and 0.9% for bla.sub.CMY. The two high prevalent phylotypes were B2 (29.2%) and D (17.9%) followed by E (14.1%), F (9.4%), C (6.6%) and 10.3% of isolates were unknown in phylotyping. Disc diffusion results showed high prevalence of antibiotic resistance to cefotaxime (88.6%), aztreonam (83%), ceftireaxon (77.3%), ceftazidime (76.4%) and ciprofloxacin (55.6%). Totally, 52.8% of isolates were found as phenotypical ESBL-producers. This study's results confirmed an explosion of antibiotic resistance amongst E. coli isolates from UTI against [beta]-lactams and fluoroquinolones. Findings explain the necessity of deep changes in quantity and quality of drug resistance diagnosis and antibiotic therapy strategies. More studies are suggested to better and confident evaluations.</description><subject>Beta lactamases</subject><subject>Causes of</subject><subject>Ciprofloxacin</subject><subject>Communicable diseases</subject><subject>Drug resistance in microorganisms</subject><subject>Drug therapy</subject><subject>Escherichia coli</subject><subject>Genetic aspects</subject><subject>Identification and classification</subject><subject>Phylogeny</subject><subject>Risk factors</subject><subject>Statistics</subject><subject>Urinary tract infections</subject><issn>1471-2180</issn><issn>1471-2180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNptkN9LwzAQx4soOKf_gE8BnwQ7kzQm6eMY6iYDwR9PIiNNkzbSNTNJh_2D_D9N0YcN5DjuuPvc945LknMEJwhxeu0R5pSmEGfROYUpO0hGiDCUYsTh4U5-nJx4_wEhYjxjo-R7bqoabJzaika1UgGrwVuhgnhPGyGDWAPRlkA3nXX2szOtbWyrgFPe-CAG3rRgK5yxnQebum9s6DfKDyq3XtbKGVkbAaRtDDDeNiLEpnZ2DTpnWuF6EFxcE1W0ksHY1g-CD8ZZHYA0ob8CCyfa0-RIi8ars784Tl7vbl9m83T5eL-YTZdphSCiqSpyiDjJiNYMljTLNeElF5gwzInCGGUaEqRzoTkr6E0Jc4iR5ByqnCHJimycXPzqVvEbq3iUHc5bGy9XU0YopTnPaKQm_1DRSrU2Mv5Hm1jfG7jcG4hMUF-hEp33q8Xz0y77AxM7jl8</recordid><startdate>20230422</startdate><enddate>20230422</enddate><creator>Afsharikhah, Saleh</creator><creator>Ghanbarpour, Reza</creator><creator>Mohseni, Parvin</creator><creator>Adib, Nasrin</creator><creator>Bagheri, Mahboube</creator><creator>Jajarmi, Maziar</creator><general>BioMed Central Ltd</general><scope>ISR</scope></search><sort><creationdate>20230422</creationdate><title>High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran</title><author>Afsharikhah, Saleh ; Ghanbarpour, Reza ; Mohseni, Parvin ; Adib, Nasrin ; Bagheri, Mahboube ; Jajarmi, Maziar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1016-eb9018434ff70d639f48d8a247284e2213f041f9af87b65d09021c880e971c7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Beta lactamases</topic><topic>Causes of</topic><topic>Ciprofloxacin</topic><topic>Communicable diseases</topic><topic>Drug resistance in microorganisms</topic><topic>Drug therapy</topic><topic>Escherichia coli</topic><topic>Genetic aspects</topic><topic>Identification and classification</topic><topic>Phylogeny</topic><topic>Risk factors</topic><topic>Statistics</topic><topic>Urinary tract infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Afsharikhah, Saleh</creatorcontrib><creatorcontrib>Ghanbarpour, Reza</creatorcontrib><creatorcontrib>Mohseni, Parvin</creatorcontrib><creatorcontrib>Adib, Nasrin</creatorcontrib><creatorcontrib>Bagheri, Mahboube</creatorcontrib><creatorcontrib>Jajarmi, Maziar</creatorcontrib><collection>Gale In Context: Science</collection><jtitle>BMC microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Afsharikhah, Saleh</au><au>Ghanbarpour, Reza</au><au>Mohseni, Parvin</au><au>Adib, Nasrin</au><au>Bagheri, Mahboube</au><au>Jajarmi, Maziar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran</atitle><jtitle>BMC microbiology</jtitle><date>2023-04-22</date><risdate>2023</risdate><volume>23</volume><issue>1</issue><issn>1471-2180</issn><eissn>1471-2180</eissn><abstract>Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common [beta]-lactam resistance genes including bla.sub.TEM, bla.sub.SHV, bla.sub.CTX-M and bla.sub.CMY and phenotypic resistance to commonly used [beta]-lactam and fluoroquinolone antibiotics in UTIs. These factors were evaluated in various phylogenetic groups (phylotypes) of E. coli isolates. Real-time PCR was applied to detect [beta]-lactam resistance genes and conventional PCR was used to determine the phylotypes. Phenotypic resistance against [beta]-lactams (ceftazidime, cefotaxime, aztreonam and ceftriaxone) and fluoroquinolones (ciprofloxacin) were identified by the disc diffusion technique. The ability of extended spectrum [beta]-lactamases (ESBLs) production in E. coli isolates was detected using the combined disc diffusion method. The prevalence of resistance genes were 89.6% for bla.sub.TEM, 44.3% for bla.sub.CTX-M, 6.6% for bla.sub.SHV and 0.9% for bla.sub.CMY. The two high prevalent phylotypes were B2 (29.2%) and D (17.9%) followed by E (14.1%), F (9.4%), C (6.6%) and 10.3% of isolates were unknown in phylotyping. Disc diffusion results showed high prevalence of antibiotic resistance to cefotaxime (88.6%), aztreonam (83%), ceftireaxon (77.3%), ceftazidime (76.4%) and ciprofloxacin (55.6%). Totally, 52.8% of isolates were found as phenotypical ESBL-producers. This study's results confirmed an explosion of antibiotic resistance amongst E. coli isolates from UTI against [beta]-lactams and fluoroquinolones. Findings explain the necessity of deep changes in quantity and quality of drug resistance diagnosis and antibiotic therapy strategies. More studies are suggested to better and confident evaluations.</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s12866-023-02860-7</doi></addata></record>
fulltext fulltext
identifier ISSN: 1471-2180
ispartof BMC microbiology, 2023-04, Vol.23 (1)
issn 1471-2180
1471-2180
language eng
recordid cdi_gale_infotracmisc_A746669836
source DOAJ Directory of Open Access Journals; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Beta lactamases
Causes of
Ciprofloxacin
Communicable diseases
Drug resistance in microorganisms
Drug therapy
Escherichia coli
Genetic aspects
Identification and classification
Phylogeny
Risk factors
Statistics
Urinary tract infections
title High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T09%3A49%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20prevalence%20of%20%5Bbeta%5D-lactam%20and%20fluoroquinolone%20resistance%20in%20various%20phylotypes%20of%20Escherichia%20coli%20isolates%20from%20urinary%20tract%20infections%20in%20Jiroft%20city,%20Iran&rft.jtitle=BMC%20microbiology&rft.au=Afsharikhah,%20Saleh&rft.date=2023-04-22&rft.volume=23&rft.issue=1&rft.issn=1471-2180&rft.eissn=1471-2180&rft_id=info:doi/10.1186/s12866-023-02860-7&rft_dat=%3Cgale%3EA746669836%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A746669836&rfr_iscdi=true